1. Effects of the anti-inflammatory drug celecoxib on cell death signaling in human colon cancer
   Ryuto Maruyama et al, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. Differential expression of cyclooxygenase-2 and cyclin D1 in salivary gland tumors
   Jefferson da Rocha Tenório et al, 2018, European Archives of Oto-Rhino-Laryngology CrossRef
3. Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survival
   Meilin Ye et al, 2023, Cell Death Discovery CrossRef
4. Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines
   Zhe Sun et al, 2022, International Journal of Peptide Research and Therapeutics CrossRef
5. Expression and prognostic value of PRDX family in colon adenocarcinoma by integrating comprehensive analysis and in vitro and in vivo validation
   He Zhou et al, 2023, Frontiers in Oncology CrossRef
6. Nrf2-peroxiredoxin I axis in polymorphous adenocarcinoma is associated with low matrix metalloproteinase 2 level
   J. M. Brod et al, 2017, Virchows Archiv CrossRef
7. Deregulation of lysophosphatidic acid metabolism in oral cancer promotes cell migration via the up-regulation of COX-2
   Mariati Abdul Rahman et al, 2020, PeerJ CrossRef
8. SIGNET: single-cell RNA-seq-based gene regulatory network prediction using multiple-layer perceptron bagging
   Qinhuan Luo et al, 2022, Briefings in Bioinformatics CrossRef
9. Targeting Peroxiredoxin 1 by a Curcumin Analogue, AI-44, Inhibits NLRP3 Inflammasome Activation and Attenuates Lipopolysaccharide-Induced Sepsis in Mice
   Wen Liu et al, 2018, The Journal of Immunology CrossRef
10. Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma
    Yajun Shen et al, 2021, Cancer Management and Research CrossRef
11. The prognostic values of the peroxiredoxins family in ovarian cancer
    Saisai Li et al, 2018, Bioscience Reports CrossRef